Statement Of Financial Position [Abstract]

Transgene - Filing #2810940

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Intangible assets other than goodwill	80,000 EUR	—	—	—	—	—	—	—	77,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	15 666 EUR	—	—	—	—	—	—	—	4 403 EUR	—	—	—	—	—	—	—	—	—	5 911 EUR	—	—	—	—	—
Assets	45 217 EUR	—	—	—	—	—	—	—	66 436 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	50 426 EUR	—	—	—	—	—	—	—	50 102 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	15 612 EUR	—	—	—	—	—	—	—	37 841 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity	—	83 432 EUR	22 328 EUR	432,000 EUR	71 156 EUR	50 426 EUR	15 612 EUR	642,000 EUR	—	50 628 EUR	32 804 EUR	808,000 EUR	450,000 EUR	70 813 EUR	50 102 EUR	37 841 EUR	19 536 EUR	2 933 EUR	—	31 092 EUR	1 423 EUR	67 209 EUR	67 441 EUR	48 886 EUR
Liabilities [abstract]
Liabilities	29 605 EUR	—	—	—	—	—	—	—	28 595 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	45 217 EUR	—	—	—	—	—	—	—	66 436 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—